An overview of key considerations shaping the BGM and CGM decision, why both often coexist in trials today, and how eCOA platforms play a critical role in supporting this data collection at scale.
Karl McEvoy, PhD, and Aubrey Verna
Advertisement
Articles by Karl McEvoy, PhD, and Aubrey Verna
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
AI Everywhere: Architecting the Future of Clinical Trials
3
Balancing Human Oversight and Automation in AI-Driven Trials
4
AI in Action: Breaking Down Clinical Trial Bottlenecks
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
